| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |